# Chang An Hui Tong Fund

> Chang An Hui Tong Fund is a VC fund in Xian Shi backing Medical, Biopharma and Health Care. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Xian Shi, China
- Total investments: 5
- Last investment: Aug 2024
- Lead investor: 60%
- Last updated: Aug 2026
- Website: https://www.ca-ht.com/

Chang An Hui Tong Fund is a VC fund in Xian Shi focused on Medical and Biopharma. Chang'an Huitong is the provincial state-owned capital operation company in the province approved by the provincial government.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 40% |
| Biopharma | 1 | 20% |
| Health Care | 1 | 20% |
| Biotechnology | 1 | 20% |
| Manufacturing | 1 | 20% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 2 | 40% |
| Series A | 1 | 20% |
| Series B | 1 | 20% |
| Venture - Series Unknown | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Shaanxi Xifeng Liquor | Shaanxi Xifeng Liquor Co,.LTD is a flavored liquor manufacturing company. | $68.7M | Venture - Series Unknown | Aug 05, 2024 |  |
| Bio Regenmed | Bioregeneration is a national high-tech industrial firm that creates and manufactures innovative biomedical materials with the goal of human tissue engineering and organ repair. |  | Series C | Dec 28, 2023 |  |
| ECHINT | ECHINT is a global advanced semiconductor packaging and testing services technology company that offers customers with one-stop packaging and testing services and solutions such as packaging design, chip packaging, and testing. | $137.3M | Series B | Aug 18, 2023 |  |
| Feidie XR Technology | Feidie XR Technology help users quickly create XR content and multi-person interactive Metaverse applications without coding. |  | Series A | Feb 13, 2023 |  |
| Micot | Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, abiological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like. | $14.7M | Series C | Feb 10, 2023 |  |

5 of 5 investments shown.

## Co-investors
- [Anxi Investment](https://shizune.co/investors/profile/anxi-investment) — VC Fund, 1 deal together
- [Beite Fund](https://shizune.co/investors/profile/beite-fund) — VC Fund, 1 deal together
- [Chengdu Science and Technology Innovation Investment Group](https://shizune.co/investors/profile/chengdu-science-and-technology-innovation-investment-group) — VC Fund, 1 deal together
- [Chengdu Science and Technology Venture Capital](https://shizune.co/investors/profile/chengdu-science-and-technology-venture-capital-group) — VC Fund, 1 deal together
- [Dongfang Jiangxia Industrial Investment](https://shizune.co/investors/profile/dongfang-jiangxia-industrial-investment) — VC Fund, 1 deal together
- [Infore Capital](https://shizune.co/investors/profile/infore-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Enterprise Software Investors in China](https://shizune.co/investors/enterprise-software-investors-china)

## FAQ

### What does Chang An Hui Tong Fund invest in?

Chang An Hui Tong Fund invests primarily in Medical, Biopharma and Health Care startups, most often at Series C and Series A stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Chang An Hui Tong Fund last invest?

The most recent investment recorded for Chang An Hui Tong Fund closed in Aug 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co